These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1438009)

  • 1. Investigation of the degradation mechanism of 5-aminosalicylic acid in aqueous solution.
    Palsmeier RK; Radzik DM; Lunte CE
    Pharm Res; 1992 Jul; 9(7):933-8. PubMed ID: 1438009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and in vitro release of 5-aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydride--P(CBFAS).
    Cai QX; Zhu KJ; Chen D; Gao LP
    Eur J Pharm Biopharm; 2003 Mar; 55(2):203-8. PubMed ID: 12637098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reaction of 5-aminosalicylic acid with peroxyl radicals: protection and recovery by ascorbic acid and amino acids.
    López-Alarcón C; Rocco C; Lissi E; Carrasco C; Squella JA; Nuñez-Vergara L; Speisky H
    Pharm Res; 2005 Oct; 22(10):1642-8. PubMed ID: 16180121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of 5-aminosalicylic acid by hypochlorous acid to a reactive iminoquinone. Possible role in the treatment of inflammatory bowel diseases.
    Liu ZC; McClelland RA; Uetrecht JP
    Drug Metab Dispos; 1995 Feb; 23(2):246-50. PubMed ID: 7736919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of mesalamine in rectal suspension diluted with distilled water.
    Henderson LM; Johnson CE; Berardi RR
    Am J Hosp Pharm; 1994 Dec; 51(23):2955-7. PubMed ID: 7879807
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recent therapeutic modalities in chronic inflammatory bowel diseases: 4- or 5-aminosalicylic acid?].
    Allgayer H; Klotz U; Böhne P; Schmidt M; Kruis W
    Z Gastroenterol; 1994 Nov; 32(11):647-50. PubMed ID: 7886975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects.
    Grisham MB; Ware K; Marshall S; Yamada T; Sandhu IS
    Dig Dis Sci; 1992 Sep; 37(9):1383-9. PubMed ID: 1505290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis.
    Ahmad S; Tester RF; Corbett A; Karkalas J
    Carbohydr Res; 2006 Nov; 341(16):2694-701. PubMed ID: 16973138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of oxidation products of 5-aminosalicylic acid in faeces and the study of their formation in vitro.
    Jensen J; Cornett C; Olsen CE; Bondesen S; Christensen J; Christensen LA; Tjørnelund J; Hansen SH
    Biochem Pharmacol; 1993 Mar; 45(6):1201-9. PubMed ID: 8385459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical-derived oxidation products of 5-aminosalicylic acid and N-acetyl-5-aminosalicylic acid.
    Fischer C; Klotz U
    J Chromatogr B Biomed Appl; 1994 Nov; 661(1):57-68. PubMed ID: 7866552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized 5-aminosalicylic acid activates Nrf2-HO-1 pathway by covalently binding to Keap1: Implication in anti-inflammatory actions of 5-aminosalicylic acid.
    Kang S; Kim W; Jeong S; Lee Y; Nam J; Lee S; Jung Y
    Free Radic Biol Med; 2017 Jul; 108():715-724. PubMed ID: 28473247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New metabolites of the drug 5-aminosalicylic acid. I: N-beta-D-glucopyranosyl-5-aminosalicylic acid.
    Tjørnelund J; Hansen SH; Cornett C
    Xenobiotica; 1989 Aug; 19(8):891-9. PubMed ID: 2815831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant effect of 5-amino salicylic acid on copper-mediated LDL oxidation.
    López-Alarcón C; Speisky H; Lissi E
    Biol Res; 2007; 40(2):155-62. PubMed ID: 18064352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the electrochemical properties of some colon-specific prodrugs of mesalazine.
    Nigović B; Simunić B; Mandić Z
    Pharmazie; 2002 Jul; 57(7):468-70. PubMed ID: 12168527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A validated HPLC method with electrochemical detection for simultaneous assay of 5-aminosalicylic acid and its metabolite in human plasma.
    Palumbo G; Bacchi S; Primavera L; Palumbo P; Carlucci G
    Biomed Chromatogr; 2005 Jun; 19(5):350-4. PubMed ID: 15586374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of Mesalamine under Phenoloxidase- or Peroxidase-like Enzyme Catalysis.
    El Zein R; Ispas-Szabo P; Jafari M; Siaj M; Mateescu MA
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim YM
    J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltammetric studies of 2-hydroxy-5-[(4-sulfophenyl)azo]benzoic acid as a novel prodrug of 5-aminosalicylic acid.
    Nigović B; Mandić Z; Simunić B; Fistrić I
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):987-94. PubMed ID: 11600311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-ASA loaded chitosan-Ca-alginate microparticles: Preparation and physicochemical characterization.
    Mladenovska K; Cruaud O; Richomme P; Belamie E; Raicki RS; Venier-Julienne MC; Popovski E; Benoit JP; Goracinova K
    Int J Pharm; 2007 Dec; 345(1-2):59-69. PubMed ID: 17616284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.